Preserving fertility in patients undergoing treatment for breast cancer: current perspectives

QR Code

Preserving fertility in patients undergoing treatment for breast cancer: current perspectives

Rebecca Moffat,1 Uwe Güth2 1Women’s Hospital, Clinic for Gynecologic Endocrinology and Reproductive Medicine, University Hospital Basel, Basel, 2Department of Gynecology and Obstetrics, Breast Center, SenoSuisse, Cantonal Hospital Winterthur, Winterthur, Switzerland Abstract: In...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Moffat R, Güth U
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2014
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/8a52c3b14f614593b150107f40da4d5c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Exercise after breast cancer treatment: current perspectives
par: Dieli-Conwright CM, et autres
Publié: (2015)

Hypofractionated whole breast radiotherapy: current perspectives
par: Koulis TA, et autres
Publié: (2015)

Multidrug-resistant breast cancer: current perspectives
par: Martin HL, et autres
Publié: (2014)

Current strategies for the prevention of breast cancer
par: Advani P, et autres
Publié: (2014)

Breast reconstruction: current and future options
par: Paul Jr H, et autres
Publié: (2011)

Current perspectives on CHEK2 mutations in breast cancer
par: Apostolou P, et autres
Publié: (2017)

Triple negative breast cancer: an Indian perspective
par: Akhtar M, et autres
Publié: (2015)

Immunotherapy in breast cancer: A clinician's perspective
par: Sibapriya Chaudhuri, et autres
Publié: (2021)

Symptom report in detecting breast cancer-related lymphedema
par: Fu MR, et autres
Publié: (2015)

A common goal to CARE: Cancer Advocates, Researchers, and Clinicians Explore current treatments and clinical trials for breast cancer brain metastases
par: Natalie S. Joe, et autres
Publié: (2021)

Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective
par: Machado M, et autres
Publié: (2012)

Targeting PD-1/PD-L1 in lung cancer: current perspectives
par: González-Cao M, et autres
Publié: (2015)

Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge
par: Grace G. Bushnell, et autres
Publié: (2021)

Breast cancer in Brazil: epidemiology and treatment challenges
par: Cecilio AP, et autres
Publié: (2015)

Profile of neratinib and its potential in the treatment of breast cancer
par: Feldinger K, et autres
Publié: (2015)

Cardiac risk in the treatment of breast cancer: assessment and management
par: Valachis A, et autres
Publié: (2015)

Challenges in the development of future treatments for breast cancer stem cells
par: Shyam A Patel, et autres
Publié: (2010)

Role of pertuzumab in the treatment of HER2-positive breast cancer
par: Hubalek M, et autres
Publié: (2012)

Breast cancer causes and treatment: where are we going wrong?
par: Seymour CB, et autres
Publié: (2013)

New developments in the treatment of HER2-positive breast cancer
par: Nahta R
Publié: (2012)

Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy
par: Abramson RG, et autres
Publié: (2012)

Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatment
par: Kidd LR, et autres
Publié: (2013)

Management of early breast cancer in older women: from screening to treatment
par: Elomrani F, et autres
Publié: (2015)

Clinical evidence of the efficacy of everolimus and its potential in the treatment of breast cancer
par: Saksena R, et autres
Publié: (2013)

Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
par: Cadoo KA, et autres
Publié: (2014)

Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer
par: Oostra DR, et autres
Publié: (2014)

Potential of afatinib in the treatment of patients with HER2-positive breast cancer
par: Geuna E, et autres
Publié: (2012)

The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
par: Moya-Horno I, et autres
Publié: (2015)

Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families
par: Thibaut S. Matis, et autres
Publié: (2021)

Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update
par: Schneider RE, et autres
Publié: (2011)

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
par: Hurvitz SA, et autres
Publié: (2012)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
par: Criscitiello C, et autres
Publié: (2018)

Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development
par: Ke Cheng, et autres
Publié: (2021)

Intraoperative radiation therapy for breast cancer patients: current perspectives
par: Dutta SW, et autres
Publié: (2017)

Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation
par: Kang Wang, et autres
Publié: (2021)

Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
par: Sawaki M
Publié: (2014)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
par: Jennifer Xiao, et autres
Publié: (2021)

Association of APOE4 genotype and treatment with cognitive outcomes in breast cancer survivors over time
par: Kathleen Van Dyk, et autres
Publié: (2021)

Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
par: Allen Li, et autres
Publié: (2021)

Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer
par: Philip D. Poorvu, et autres
Publié: (2021)